Skip to main content
Peter Klein, MD, Hematology, Philadelphia, PA, Hospital of the University of Pennsylvania

PeterSKleinMD

Hematology Philadelphia, PA

Associate Professor, Medicine, Perelman School of Medicine

Are you Dr. Klein?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 63 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Peter Klein, MD is a hematologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Hospital of the University of Pennsylvania and is an Associate Professor at Perelman School of Medicine.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2000 - 2005
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1988 - 1991
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1988

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1995 - 2024

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 2003
  • Investigator Alumnus Howard Hughes Medical Institute, 1995

Publications & Presentations

PubMed

Grant Support

  • Targeting WNT And Mtor To Expand Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute2011–2012
  • Regulating Hematopoietic Stem Cell Homeostasis Through GSK-3National Heart, Lung, And Blood Institute2011–2012
  • A Molecular Mechanism For Lithium ActionNational Institute Of Mental Health2001–2010
  • Early Activation Of The Zygotic GenomeNational Institute Of General Medical Sciences2006–2009
  • Phase II Trial Of Valproic Acid In MyelodysplasiaNational Cancer Institute2005–2006
  • A Novel Molecular Target Of Valproic AcidNational Institute Of Mental Health2002–2006
  • Molecular Mechanism For Lithium ActionNational Institute Of Mental Health1998–2000
  • Molecular Target Of Lithium In Affective DisordersNational Institute Of Mental Health1997–1998

Hospital Affiliations